Pharmafile Logo
Pharmafocus logo
Advanced Search

China

Showing 15 posts of 258 posts found.

Sanofi boosts emerging markets leadership team

January 11, 2011
Sales and Marketing Brazil, China, Heraldo Marchezini, Japan, Jeremy Moulding Russia, Patrick Aghanian, Sanofi-Aventis, Thomas Kelly, appointments, emerging markets, sales and marketing

Sanofi-Aventis has bolstered its emerging markets team with the appointment of four senior managers. They are Patrick Aghanian, Thomas Kelly, …

Appointment

2010: Pharma’s year in review

December 23, 2010
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2010, Avandia, China, European healthcare spending, GSK, Obama, year in review

2010 saw a harsh new economic reality dominate decisions in the US and Europe, but pharma seized on opportunities in …

Feature

Pharma careers options – management in China

December 17, 2010
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, careers, management, recruitment

Substantial growth is predicted over the coming years in China, so how should the life sciences industry approach appointing the …

Feature

China to ‘overtake US in innovation by 2020’

December 13, 2010
Research and Development, Sales and Marketing AstraZeneca, China, India, innovation

China will replace the US as the number one ‘powerhouse of innovation’ within the next ten years according to a …

News

GSK acquires China’s Nanjing MeiRui Pharma for $70m

December 8, 2010
Manufacturing and Production, Sales and Marketing China, GSK, GlaxoSmithKline, Nanjing MeiRui Pharma, Pagoda Pharmaceuticals, SheNiTing

GlaxoSmithKline has continued its expansion into China with the $70 million acquisition of a local firm. Nanjing MeiRui Pharma Co’s …

News
Lilly scientists

Lilly to open diabetes research centre in China

November 2, 2010
Research and Development China, Eli Lilly & Co, Lilly Research Laboratories in China, diabetes, lilly

The march of foreign pharma companies into China is to continue with Eli Lilly and Co’s opening of a diabetes …

News

Nycomed expands China presence with Techpool stake

November 2, 2010
Research and Development, Sales and Marketing China, Guangdong Techpool biopharma, Nycomed, emerging markets, emerging pharma markets

Swiss-based Nycomed has acquired a majority stake in Guangdong Techpool biopharma in China, extending its presence in the top tier …

News

Conducting clinical trials in China

October 26, 2010
Research and Development China, Jim Wei, Medpace, clinical trials, clinical trials in Chaia, regulatory affairs

As industry pressure to conduct successful global clinical trials on time and on budget continue, tapping emerging global markets will …

Feature

China driving global pharma growth

October 13, 2010
Sales and Marketing China, emerging markets, sales

The global pharma market is forecast to reach $880 billion by 2011, driven by growth in the Chinese market. Analysts …

News

EU trailing as China moves ahead with master file plans

September 28, 2010
Manufacturing and Production API, China, EU, excipients

There has been progress in China on the development of drug master files for pharmaceutical ingredients and components, highlighting once …

News

Novo expands diabetes research in China

September 16, 2010
Research and Development China, Novo Nordisk, diabetes

Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …

News

Bayer signs Chinese research deal

July 20, 2010
Research and Development Bayer, China, gynaecology

Bayer is partnering with the People’s Liberation Army General Hospital in Beijing on research into women’s healthcare. The People’s Liberation …

News

ICON and Tigermed forge China alliance

April 7, 2010
Research and Development CRO, China, ICON

Contract research organisation ICON is to team up with Tigermed Consulting, a clinical services company based in China. The alliance …

News

IMS adds countries to ‘pharmerging’ hit-list

March 18, 2010
Sales and Marketing China, IMS, em

IMS Health has added 10 more countries to its list of ‘pharmerging markets’ which represent the future of pharma industry …

News

WuXi’s growth slows

March 17, 2010
Research and Development CRO, China, WuXi

WuXi Pharmatech, one of China’s leading contract research organisations, has been motoring ahead in recent quarters while its western counterparts …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026